Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1197)
  3. Review (75)
  4. Research Letter (49)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2970)
  2. Department of Medicine (2970)
  3. Hematologic Malignancies, Division of (2847)
  4. Survivorship Research (1388)
  5. GSK Faculty (931)
  6. CTCR Scholars (873)

More Groups

People
  1. Sergio Giralt (1068)
  2. Miguel-Angel Perales (943)
  3. Sean Devlin (470)
  4. Ann Jakubowski (459)
  5. Gunjan Shah (446)
  6. Heather Landau (435)

More People

Years
  1. 2025 (67)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (94)

More Publications

Publishers
  1. American Society of Hematology (988)
  2. Elsevier Inc. (767)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2970)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and immunogenicity of the 13-valent protein-conjugated pneumococcal vaccine(PCV13) following related and unrelated hematopoietic stem cell transplantation (HCT)
    Meeting Abstract

    Small, T. N.; Jakubowski, A. A.; Barker, J. N.; Kernan, N. A.; Prockop, S. E.; Iovino, C. S.; Lestrange, N.; Perales, M. A.; Castro-Malaspina, H.; Koehne, G.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Non-myeloablative allogeneic hematopoietic stem cell transplantation with low-dose total body irradiation and peri-transplant rituximab for B cell non-Hodgkin lymphoma: Favorable disease control in chemosensitive patients
    Meeting Abstract

    Sauter, C. S.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; Lechner, L.; Moskowitz, C. H.; Giralt, S.; Barker, J. N.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • T-cell depleted (TCD) hematopoietic stem cell (HSC) boosts from the original donor without conditioning for poor graft function (PGF) following allogeneic hematopoietic stem cell transplants (HSCT)
    Meeting Abstract

    Rosenzweig, M. A.; Kernan, N. A.; Small, T. N.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M. A.; Boulad, F.; Giralt, S.; Young, J. W.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • A randomized phase II trial of fludarabine/melphalan 140 vs fludarabine/melphalan 100 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
    Meeting Abstract

    Qazilbash, M.; Thall, P. F.; Liu, P.; Orlowski, R. Z.; Bashir, Q.; Shah, N.; Kebriaei, P.; Parmar, S.; Jones, R.; Hosing, C. M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Graft-versus-host disease (GVHD) after double-unit cord blood transplantation (DCBT) is associated with unique clinical features including a higher incidence of grade III-IV acute GVHD in children
    Meeting Abstract

    Ponce, D. M.; Gonzales, A. M.; Lubin, M. N.; Castro-Malaspina, H.; Giralt, S. A.; Goldberg, J. D.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M. A.; van den Brink, M. R. M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Phase I/II trial of fludarabine in combination with intravenous busulfan and allogeneic progenitor cell support for patients with high risk hematologic malignancies; Dose matters in reduced intensity regimens
    Meeting Abstract

    Parmar, S.; Rondon, G.; Thall, P. F.; Bassett, R.; de Lima, M.; Hosing, C. M.; Anderlini, P.; Kebriaei, P.; Khouri, I.; Ganesan, P.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Urinary excretion of epinephrine and dopamine correlates with efficiency of G-CSF mobilized stem cells in patients with AL amyloidosis
    Meeting Abstract

    Landau, H.; Hassoun, H.; Hoffman, J. E.; Bello, C.; Hoover, E.; Riedel, E.; Frenette, P. S.; Comenzo, R. L.
    Blood (2011)

    Fulltext@MSK | Save
  • Chromosome 7 abnormalities in allogeneic transplantation for AML and MDS
    Meeting Abstract

    Kota, V.; Saliba, R. M.; Bayraktar, U. D.; Beitinjaneh, A.; Chen, J. J.; Parmar, S.; Giralt, S. A.; Rondon, G.; Ciurea, S. O.; Kebriaei, P.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic hematopoietic stem cell transplantation with busulfan, melphalan, and fludarabine conditioning followed by post transplantation donor lymphocyte infusions for patients with relapsed multiple myeloma and high-risk cytogenetics
    Meeting Abstract

    Koehne, G.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Rosenzweig, M. A.; Heller, G.; Giralt, S.
    Blood (2011)

    Fulltext@MSK | Save
  • Improved survival in patients with refractory cytopenias (low risk myelodysplastic syndrome - MDS) treated with allogeneic T-cell depleted hematopoietic stem cell transplants (allo TCD-HSCTs)
    Meeting Abstract

    Jhaveri, A.; Papadopoulos, E. B.; Jakubowski, A. A.; Boulad, F.; Kernan, N. A.; Small, T. N.; Perales, M. A.; Maloy, M.; Montes-Gaisan, C.; O'Reilly, R. J.; more...
    Blood (2011)

    Fulltext@MSK | Save